Quantum-Si (QSI) Projected to Post Earnings on Monday

Quantum-Si (NASDAQ:QSI) is projected to release its earnings data after the market closes on Monday, March 3rd. Analysts expect Quantum-Si to post earnings of ($0.18) per share and revenue of $1.23 million for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Quantum-Si Price Performance

QSI stock opened at $1.38 on Friday. The firm has a market cap of $196.94 million, a PE ratio of -2.16 and a beta of 2.70. Quantum-Si has a 12 month low of $0.61 and a 12 month high of $5.77. The firm has a 50 day simple moving average of $2.23 and a 200 day simple moving average of $1.43.

Insiders Place Their Bets

In other Quantum-Si news, Director Jonathan M. Rothberg sold 3,506,267 shares of Quantum-Si stock in a transaction on Friday, December 27th. The shares were sold at an average price of $3.34, for a total transaction of $11,710,931.78. Following the completion of the sale, the director now owns 1,250,000 shares of the company’s stock, valued at $4,175,000. This trade represents a 73.72 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 30.04% of the company’s stock.

Analysts Set New Price Targets

QSI has been the subject of several research reports. HC Wainwright reissued a “buy” rating and set a $5.50 price objective on shares of Quantum-Si in a research note on Tuesday, January 14th. Alliance Global Partners initiated coverage on Quantum-Si in a research report on Friday, February 7th. They issued a “buy” rating and a $3.75 price target for the company. Finally, Canaccord Genuity Group cut their price objective on Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a report on Wednesday, November 13th.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.